Esomeprazole and omeprazole could boost the serum concentrations of benzodiazepines (by using CYP2C19 inhibition) leading to enhanced adverse effects such as drowsiness, although the clinical relevance is minimal in the majority of clients – observe the patient for adverse effects (e. If affected individual are unable to resume their normal https://medeusresearchchem.com/product-category/research-chemicals/